Deborah A. Figueroa

<i>In Vitro</i> Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy

Kady Phe, Yuman Lee, Patrick M. McDaneld et al. · Antimicrobial Agents and Chemotherapy · 2014 · 178 citations · Full text

Urology, Renal Function, Health Sciences +15

Safety of High‐Dose Intravenous Daptomycin Treatment: Three‐Year Cumulative Experience in a Clinical Program

Deborah A. Figueroa, Elisabetta Mangini, Maria Amodio-Groton et al. · Clinical Infectious Diseases · 2009 · 153 citations · Full text

Risk factors for nephrotoxicity onset associated with polymyxin B therapy

Yanina Dubrovskaya, Nishant Prasad, Yuman Lee et al. · Journal of Antimicrobial Chemotherapy · 2015 · 63 citations · Full text

Use of Daptomycin for the Treatment of Methicillin-Resistant Coagulase-Negative Staphylococcal Ventriculitis

Mohamed Erritouni, Nessrine Ktaich, James J. Rahal et al. · Case Reports in Medicine · 2012 · 22 citations · Full text

Evd-related Infection, Antimicrobial Susceptibility, Health Sciences +13

Stability of polymyxin B sulfate diluted in 0.9% sodium chloride injection and stored at 4 or 25 °C

Jie He, Deborah A. Figueroa, Tze-Peng Lim et al. · American Journal of Health-System Pharmacy · 2010 · 14 citations